What's new?

CALIXAR will meet international investors at the 20th Annual Biotech in Europe Forum, 21-24 Sept 2020

September 10, 2020

New publication to better understand the machinery around neurotransmitter receptor channels

August 20, 2020

New Detergent‐Like Polymerizable Monomers for membrane protein extraction

July 28, 2020

CALIXAR and Bioinborn Scientific Inc. to conclude distribution agreement

July 23, 2020

Current structural view on neuronal KCC therapeutic targets family

July 3, 2020

CALIXAR launches its new website!

June 24, 2020

New publication on Integral Membrane Protein Oligomers Isolation

June 23, 2020

CALIXAR is willing to contribute to stop outbreak of Coronavirus

February 19, 2020

CALIXAR, industrial representative at FRISBI Industrial Days, Paris 3-4 February

January 30, 2020

CALIXAR obtient le renouvellement de son agrément « Crédit d’Impôt Recherche » (CIR) pour 3 ans

January 23, 2020

Happy New Year 2020 !

January 13, 2020

New grant for membrane protein stabilization chemistry

November 14, 2019

New vaccine formulation against influenza infection

October 24, 2019

Novel influenza vaccine : Calixar patent granted in Europe

October 15, 2019

New publication on Calixar’s stabilization expertise for native MPs

September 23, 2019

Novel innovative detergent family for MP extraction and stabilization

September 6, 2019

Calixar novel patent publication

September 4, 2019

New publications on MRP4 solubilization and stabilization

August 26, 2019

Calixar and VirPath patent granted in the United States

June 17, 2019

New glycosylated calixarene-based detergent for MP stabilization

May 29, 2019

MemTrain EU-Cofund Award

May 15, 2019

CALIXAR presentation at PEGS Summit: 08-12 April 2019

March 13, 2019

PROMETEUS Kick-Off Meeting – February 18-19, 2019

February 20, 2019

Novel innovative detergent family for MP extraction and stabilization

February 20, 2019

Happy New Year 2019!

January 1, 2019

New publication in Cancers

November 23, 2018

Novel innovative detergent family for membrane-protein extraction

July 11, 2018

New publication on native GPCR stabilization

May 28, 2018

CALIXAR Best Inventing French-Tech Company 2018

May 16, 2018

New Review on Membrane Proteins

March 22, 2018

FEBS Youth Travel Fellowship Award

March 14, 2018

New Article Published

March 7, 2018

Catalogue of Reagent

February 1, 2018

First Distribution Agreement

November 24, 2017

Novel Additive Crystallization Kit

November 8, 2017

New Catalogue 2017

September 6, 2017

Shaping the future of innovative vaccination against leptospirosis

July 24, 2017

New role of the KCC2 N-Terminus on cell surface delivery

July 19, 2017

Detergent Quantification Tool

March 8, 2017

Leptospirosis Antigen Identification

February 1, 2017

Happy New Year 2017!

January 1, 2017

Novel Solubilization Screening Method

November 21, 2016

New Publication on Influenza Target

November 15, 2016

Launch of Chem2Stab

June 24, 2016

New Stabilizing Compounds

May 13, 2016

ChikVax Project Approval

April 21, 2016

New review article and award

April 8, 2016

CALIXAR in Nature Communications

March 2, 2016

Therapeutic Antibody Engineering Workshop

March 1, 2016

New US Office in Massachusetts

October 20, 2015

Calixar Patent Granted in Japan

May 12, 2015

CALIXAR Bio’Innov Laureate

April 3, 2015

Calixar raises €1 Million

February 23, 2015

Major Advances on Influenza Vaccines

February 4, 2015

Happy New Year 2015!

January 1, 2015

CALIXAR in Biocentury News

December 15, 2014

COST Action Approval

November 13, 2014

GDR3545 – 20-22 Oct 2014

October 1, 2014

New Strategic Compounds

June 16, 2014

Video presentation of CALIXAR

March 11, 2014

CALIXAR, a rising star

December 12, 2013

NETVA 2013 winners with Steve Blank @ K&S Ranch

November 13, 2013

CALIXAR joined the GDR3545 membership – GPCRs from physiology to drugs

October 16, 2013

CALIXAR to open First Commercial Branch in Japan

March 7, 2013

2012 Nobel Prize for Research on GPCR

October 12, 2012

Research Agreement with Institute of Molecular and Cellular Pharmacology

August 29, 2012

Research Agreement with Oxford University

June 13, 2012

Research Agreement with Calabria University

June 11, 2012

Research Agreement with Gottigen University

May 3, 2012

Research Agreement with Ruhr University Group

April 10, 2012

Research Agreement with Utrecht University Group

March 15, 2012

Research agreement with leading pharmaceutical company

February 29, 2012

Scientific Publication

March 31, 2011

Entrepreuneurial Network Laureate

March 23, 2011

Lyon Science Transfert Prize

November 29, 2010

Contact us

Secure and boost your discovery programs.

Starting from native material or recombinant systems, we succeed with all types of membrane proteins: GPCRs, Ions Channels, Transporters, Receptors and Viral Proteins.

© 2020 Calixar. All rights reserved.